| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1990PNAS...87.8687G |
| P356 | DOI | 10.1073/PNAS.87.22.8687 |
| P932 | PMC publication ID | 55024 |
| P698 | PubMed publication ID | 2247437 |
| P5875 | ResearchGate publication ID | 20909509 |
| P2093 | author name string | A P Rice | |
| M B Mathews | |||
| H D Robertson | |||
| S Gunnery | |||
| P2860 | cites work | Efficientin vitrosynthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter | Q27861016 |
| Control of the interferon-induced 68-kilodalton protein kinase by the HIV-1 tat gene product | Q28244407 | ||
| A double-stranded RNA unwinding activity introduces structural alterations by means of adenosine to inosine conversions in mammalian cells and Xenopus eggs | Q28274604 | ||
| Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product | Q29615049 | ||
| Vectors for selective expression of cloned DNAs by T7 RNA polymerase | Q29620230 | ||
| HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation | Q29620799 | ||
| Suppression of the translation defect phenotype specific for a virus-associated RNA-deficient adenovirus mutant in monkey cells by simian virus 40. | Q33926830 | ||
| Structural requirements of double-stranded RNA for the activation of 2‘,5‘-oligo(A) polymerase and protein kinase of interferon-treated HeLa cells | Q34221795 | ||
| Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro | Q34303073 | ||
| Complementation of adenovirus virus-associated RNA I gene deletion by expression of a mutant eukaryotic translation initiation factor | Q34322100 | ||
| Trans-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat | Q34563887 | ||
| Efficient trans-activation by the HIV-2 Tat protein requires a duplicated TAR RNA structure | Q35835407 | ||
| Activation of interferon-regulated, dsRNA-dependent enzymes by human immunodeficiency virus-1 leader RNA. | Q35864756 | ||
| Removal of double-stranded contaminants from RNA transcripts: synthesis of adenovirus VA RNAI from a T7 vector | Q35877665 | ||
| Mutational analysis of the 5' non-coding region of human immunodeficiency virus type 1: effects of secondary structure on translation | Q36062164 | ||
| Effects of mutations in stem and loop regions on the structure and function of adenovirus VA RNAI | Q36062230 | ||
| ompT encodes the Escherichia coli outer membrane protease that cleaves T7 RNA polymerase during purification | Q36195130 | ||
| Purification and properties of the replicative intermediate of the RNA bacteriophage R17 | Q36460473 | ||
| Purification and activation of the double-stranded RNA-dependent eIF-2 kinase DAI | Q36763912 | ||
| The phosphorylation state of eucaryotic initiation factor 2 alters translational efficiency of specific mRNAs | Q36767369 | ||
| Circumstances and mechanisms of inhibition of translation by secondary structure in eucaryotic mRNAs | Q36796132 | ||
| Structural requirements for trans activation of human immunodeficiency virus type 1 long terminal repeat-directed gene expression by tat: importance of base pairing, loop sequence, and bulges in the tat-responsive sequence. | Q36802812 | ||
| A mechanism by which adenovirus virus-associated RNAI controls translation in a transient expression assay | Q36834492 | ||
| Construction and analysis of additional adenovirus substitution mutants confirm the complementation of VAI RNA function by two small RNAs encoded by Epstein-Barr virus | Q36854251 | ||
| An adenovirus mutant unable to express VAI RNA displays different growth responses and sensitivity to interferon in various host cell lines | Q36901893 | ||
| Adenovirus VAI RNA prevents phosphorylation of the eukaryotic initiation factor 2 alpha subunit subsequent to infection | Q37522288 | ||
| Regulation of expression of human immunodeficiency virus | Q37783139 | ||
| Interferon and human immunodeficiency virus infection | Q38181269 | ||
| Human immunodeficiency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulation | Q38345116 | ||
| Regulatory pathways governing HIV-1 replication | Q38360638 | ||
| Regulation of HIV and HTLV gene expression | Q39289382 | ||
| Impact of virus infection on host cell protein synthesis | Q39596383 | ||
| A novel transcription property of SP6 and T7 RNA polymerases: dependence on template structure. | Q40471595 | ||
| Translational control mediated by eucaryotic initiation factor-2 is restricted to specific mRNAs in transfected cells | Q40659075 | ||
| Adenovirus VA RNAI mediates a translational stimulation which is not restricted to the viral mRNAs | Q41388647 | ||
| Interferon-induced enzymatic activities and their role in the antiviral state | Q41674497 | ||
| Escherichia coli ribonuclease III. | Q41854975 | ||
| Activation of double-stranded RNA-dependent kinase (dsl) by the TAR region of HIV-1 mRNA: a novel translational control mechanism | Q42158761 | ||
| Inhibition of mRNA binding to ribosomes by localized activation of dsRNA-dependent protein kinase | Q42445108 | ||
| Characterization of the double-stranded RNA implicated in the inhibition of protein synthesis in cells infected with a mutant adenovirus defective for VA RNA. | Q42518461 | ||
| A mechanism for the control of protein synthesis by adenovirus VA RNAI. | Q44228079 | ||
| HIV-1 tat trans-activation requires the loop sequence within tar. | Q44349676 | ||
| Demonstration of virus-specific transcriptional activator(s) in cells infected with HTLV-III by an in vitro cell-free system | Q45029117 | ||
| A developmentally regulated activity that unwinds RNA duplexes | Q45204994 | ||
| Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein | Q45830211 | ||
| Tat trans-activates the human immunodeficiency virus through a nascent RNA target | Q45847022 | ||
| In vitro formation of short RNA polymerase II transcripts that terminate within the HIV-1 and HIV-2 promoter-proximal downstream regions | Q46119240 | ||
| Structure, sequence, and position of the stem-loop in tar determine transcriptional elongation by tat through the HIV-1 long terminal repeat | Q46674379 | ||
| Catalytic RNA: a Nobel Prize for small village science | Q48405443 | ||
| Modification of protein synthesis initiation factors and the shut-off of host protein synthesis in adenovirus-infected cells | Q64379290 | ||
| Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced eIF-2 alpha kinase | Q64380153 | ||
| Sensitive methods for the detection and characterization of double helical ribonucleic acid | Q66892121 | ||
| A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation | Q68583028 | ||
| Replication of RNA by the DNA-dependent RNA polymerase of phage T7 | Q69609657 | ||
| Escherichia coli ribonuclease III cleavage sites | Q71452469 | ||
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | HIV type 1 | Q18907320 |
| P304 | page(s) | 8687-8691 | |
| P577 | publication date | 1990-11-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Tat-responsive region RNA of human immunodeficiency virus 1 can prevent activation of the double-stranded-RNA-activated protein kinase | |
| P478 | volume | 87 |
| Q41062084 | Activation of 2'-5' oligoadenylate synthetase by single-stranded and double-stranded RNA aptamers |
| Q31128979 | Activation of the protein kinase PKR by short double-stranded RNAs with single-stranded tails |
| Q36820396 | Adenovirus virus-associated RNA and translation control |
| Q34079750 | Analysis of PKR activation using analytical ultracentrifugation |
| Q34010093 | Antisense RNA: function and fate of duplex RNA in cells of higher eukaryotes. |
| Q27487338 | Bioinformatic and Physical Characterizations of Genome-Scale Ordered RNA Structure in Mammalian RNA Viruses |
| Q35697536 | Cellular autophagy: surrender, avoidance and subversion by microorganisms |
| Q43860103 | Characterization of the solution complex between the interferon-induced, double-stranded RNA-activated protein kinase and HIV-I trans-activating region RNA. |
| Q27349527 | Coronavirus gene 7 counteracts host defenses and modulates virus virulence |
| Q27472977 | Detection of genome-scale ordered RNA structure (GORS) in genomes of positive-stranded RNA viruses: Implications for virus evolution and host persistence |
| Q37639170 | Discriminating Self and Non-Self by RNA: Roles for RNA Structure, Misfolding, and Modification in Regulating the Innate Immune Sensor PKR |
| Q33750599 | Double-stranded RNA-activated protein kinase mediates virus-induced apoptosis: a new role for an old actor |
| Q24816505 | Dual role of TRBP in HIV replication and RNA interference: viral diversion of a cellular pathway or evasion from antiviral immunity? |
| Q35841536 | Effect of single-base substitutions in the central domain of virus-associated RNA I on its function. |
| Q37633114 | Evolution of a disrupted TAR RNA hairpin structure in the HIV-1 virus. |
| Q39595632 | Human immunodeficiency virus type 1 tat protein activates transcription factor NF-kappaB through the cellular interferon-inducible, double-stranded RNA-dependent protein kinase, PKR |
| Q35107434 | ICP34.5 protein of herpes simplex virus facilitates the initiation of protein translation by bridging eukaryotic initiation factor 2alpha (eIF2alpha) and protein phosphatase 1 |
| Q38060973 | Identification and utility of innate immune system evasion mechanisms of ASFV. |
| Q24672548 | Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action |
| Q36621379 | In vitro analysis of virus-associated RNA I (VAI RNA): inhibition of the double-stranded RNA-activated protein kinase PKR by VAI RNA mutants correlates with the in vivo phenotype and the structural integrity of the central domain. |
| Q35877650 | Induction of CD4 expression and human immunodeficiency virus type 1 replication by mutants of the interferon-inducible protein kinase PKR. |
| Q24538727 | Inhibition of PACT-mediated activation of PKR by the herpes simplex virus type 1 Us11 protein |
| Q36480640 | Inhibition of PKR by RNA and DNA viruses |
| Q33624495 | Inhibition of human immunodeficiency virus type 1 and vaccinia virus infection by a dominant negative factor of the interferon regulatory factor family expressed in monocytic cells |
| Q77508091 | Inhibition of the double-stranded RNA-dependent protein kinase PKR by mammalian ribosomes |
| Q41845602 | Interactions between double-stranded RNA regulators and the protein kinase DAI |
| Q34660504 | Interferon, Mx, and viral countermeasures |
| Q35680172 | Intra-host versus inter-host selection: viral strategies of immune function impairment |
| Q36839129 | Intracellular messengers and the control of protein synthesis |
| Q39876240 | Large-population passages of vesicular stomatitis virus in interferon-treated cells select variants of only limited resistance |
| Q34045759 | Low TRBP levels support an innate human immunodeficiency virus type 1 resistance in astrocytes by enhancing the PKR antiviral response |
| Q37131965 | Mechanisms employed by retroviruses to exploit host factors for translational control of a complicated proteome. |
| Q34669736 | Mechanisms of inhibition of the host interferon alpha/beta-mediated antiviral responses by viruses |
| Q40858827 | Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase |
| Q36648557 | Mutational analysis of the central domain of adenovirus virus-associated RNA mandates a revision of the proposed secondary structure |
| Q41648368 | Oligo-2',5'-adenylate synthetase activity in cells persistently infected with human T-lymphotropic virus type I (HTLV-I). |
| Q35700273 | On the role of interferon regulatory factors in HIV-1 replication. |
| Q35866566 | Paradoxical interactions between human delta hepatitis agent RNA and the cellular protein kinase PKR |
| Q34315689 | Pararetroviruses and retroviruses: a comparative review of viral structure and gene expression strategies. |
| Q36321340 | Phosphorylation and dephosphorylation events that regulate viral mRNA translation |
| Q39631116 | Potential Alu function: regulation of the activity of double-stranded RNA-activated kinase PKR. |
| Q40066451 | Premature termination and processing of human immunodeficiency virus type 1-promoted transcripts |
| Q35228905 | Protein Phosphorylation in Translational Control |
| Q41001121 | Protein synthesis in pseudorabies virus-infected cells: decreased expression of protein kinase PKR, and effects of 2-aminopurine and adenine |
| Q37389973 | RNA dimerization promotes PKR dimerization and activation |
| Q39877972 | RNA-targeted activators, but not DNA-targeted activators, repress the synthesis of short transcripts at the human immunodeficiency virus type 1 long terminal repeat. |
| Q40756505 | Regulation of human immunodeficiency virus infection: implications for pathogenesis |
| Q39718117 | Regulation of the double-stranded RNA-dependent protein kinase PKR by RNAs encoded by a repeated sequence in the Epstein-Barr virus genome |
| Q34435571 | Role and fate of PML nuclear bodies in response to interferon and viral infections |
| Q40066693 | Role of TAR RNA splicing in translational regulation of simian immunodeficiency virus from rhesus macaques |
| Q35090040 | Stimulators of translation identified during a small molecule screening campaign |
| Q35837330 | Straightening of bulged RNA by the double-stranded RNA-binding domain from the protein kinase PKR. |
| Q35273064 | TAR RNA-binding protein is an inhibitor of the interferon-induced protein kinase PKR |
| Q37328987 | Tat-responsive region RNA of human immunodeficiency virus type 1 stimulates protein synthesis in vivo and in vitro: relationship between structure and function |
| Q56794989 | The TAR RNA-binding Protein, TRBP, Stimulates the Expression of TAR-containing RNAsin Vitroandin VivoIndependently of Its Ability to Inhibit the dsRNA-dependent Kinase PKR |
| Q28306498 | The Tat protein of human immunodeficiency virus type 1 is a substrate and inhibitor of the interferon-induced, virally activated protein kinase, PKR |
| Q38960851 | The cellular TAR RNA binding protein, TRBP, promotes HIV-1 replication primarily by inhibiting the activation of double-stranded RNA-dependent kinase PKR. |
| Q37369000 | The fragile X syndrome repeats form RNA hairpins that do not activate the interferon-inducible protein kinase, PKR, but are cut by Dicer |
| Q40597354 | The human immunodeficiency virus type-1 long terminal repeat and its role in gene expression |
| Q38256883 | The influence of viral RNA secondary structure on interactions with innate host cell defences. |
| Q36346824 | The interferon response circuit: induction and suppression by pathogenic viruses |
| Q40400355 | The interferon system: a review with emphasis on the role of PKR in growth control |
| Q40852581 | The small RNAs of Epstein-Barr virus |
| Q36635734 | Transcription of the human T-cell lymphotropic virus type I promoter by an alpha-amanitin-resistant polymerase |
| Q73668790 | Transcriptional upregulation of interferon-induced protein kinase, PKR, in breast cancer |
| Q35084366 | Translation initiation and viral tricks |
| Q33935121 | Translational control of viral gene expression in eukaryotes |
| Q36686274 | Translational stimulation by reovirus polypeptide sigma 3: substitution for VAI RNA and inhibition of phosphorylation of the alpha subunit of eukaryotic initiation factor 2 |
| Q53486053 | Tumorigenesis. Suppression with a difference. |
| Q28204738 | Two dimerization domains in the trans-activation response RNA-binding protein (TRBP) individually reverse the protein kinase R inhibition of HIV-1 long terminal repeat expression |
| Q36566892 | Two functionally distinct RNA-binding motifs in the regulatory domain of the protein kinase DAI |
| Q35925617 | Variable inhibition of cell-free translation by HIV-1 transcript leader sequences |
| Q35169815 | Viral inhibition of the interferon system |
| Q37726462 | Viral strategies to subvert the mammalian translation machinery |
| Q36750723 | Viral suppression of the interferon system |
Search more.